Skip to main content

HLS · HLS Therapeutics Inc. · Financials

4.4100 CAD -0.0300 (-0.68%) At close · Nov 6 Intraday price with Plus
Market Cap
136.42M CAD
Shares
30.94M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
$55.5M -2%
FY2025 Revenue FY2024–FY2025
Net Income
-$12.43M +36.8%
FY2025 Net Income FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024
$55.5M $56.62M
-$12.88M -$15.58M
-$445K $4.07M
-$12.43M -$19.66M
-22.4% -34.71%
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.